By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > Dual Absorption Pathways Explain Why High-Dose B12 Supplements Deliver Results

Dual Absorption Pathways Explain Why High-Dose B12 Supplements Deliver Results

GMJ
Last updated: 03/06/2026 13:07
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Chart showing vitamin B12 absorption rates at different dosage levels
Research reveals how vitamin B12 supplements overcome absorption limitations through a backup pathway. While efficiency drops dramatically at high doses, total absorption continues rising significantly. — Photo: Anna Shvets / Pexels
SHARE
1 min read|125 words

Vitamin B12 supplements achieve therapeutic effectiveness through an elegant biological redundancy that compensates for the limitations of the body’s primary absorption mechanism. While the intrinsic factor pathway—the stomach’s specialized B12 transport system—saturates at approximately 1.5 micrograms per dose, a secondary passive diffusion pathway continues absorbing B12 throughout the entire digestive tract. This backup system, though less efficient, becomes increasingly valuable at higher doses. Research from Adams et al. demonstrates that despite absorption efficiency dropping to 1.3% at 1,000 microgram doses, the total amount absorbed still rises significantly. This paradox explains why high-dose oral supplements can deliver four times the daily requirement in a single pill. Understanding these two distinct mechanisms provides crucial insights into supplement formulation and clinical efficacy. Read the full article on GMJ Newsroom.

Was this article helpful?

100% of readers found this helpful (1 votes)

GMJ Brief · Announcement

📰 Read the full article: Why High-Dose Vitamin B12 Supplements Work Despite Poor Absorption →

Related reference
  • Vitamin B12 · Ingredient
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
FDA’s Pazdur Calls for Agency Restructuring Amid China Competition and Internal Upheaval

FDA's Rick Pazdur calls for fundamental agency restructuring following internal disruption, citing…

Revolution Medicines Ships Experimental Pancreatic Cancer Drug Under Early Access

Revolution Medicines begins expanded access program for daraxonrasib targeting KRAS G12C mutations.…

NHS Patient Watchdog Abolition Sparks Concerns Over Health Service Accountability

Local councils warn that government plans to abolish NHS patient watchdogs will…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Global HealthPolicy & Systems

WHO Declares International Emergency as Congo Ebola Outbreak Spreads Across Borders

By
Prof. Giorgi Pkhakadze
31/05/2026
Scientific chart showing creatine safety data from clinical trials

26,000-Person Study Provides Definitive Evidence: Creatine Supplementation Does Not Damage Kidneys

By
Prof. Giorgi Pkhakadze
03/06/2026

EBOLA OUTBREAK – DRC/UGANDA BORDER CROSSING – PHEIC DECLARED

By
Prof. Giorgi Pkhakadze
31/05/2026
UN medical personnel deploying emergency supplies for Ebola response in Democratic Republic of Congo

UN Launches Rapid-Deployment Strategy Against Eastern DRC Ebola Outbreak

By
Prof. Giorgi Pkhakadze
31/05/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up